Terns Pharmaceuticals Inc’s recent filing unveils that its Chief Executive Officer Burroughs Amy L. acquired Company’s shares for reported $0.11 million on Dec 05 ’24. In the deal valued at $7.15 per share,15,450 shares were bought. As a result of this transaction, Burroughs Amy L. now holds 19,099 shares worth roughly $0.13 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Lu Hongbo bought 476,190 shares, generating $4,999,995 in total proceeds. Upon buying the shares at $10.50, the Director now owns 476,190 shares.
Before that, Vignola Mark J. sold 10,000 shares. Terns Pharmaceuticals Inc shares valued at $110,000 were divested by the Chief Financial Officer at a price of $11.00 per share. As a result of the transaction, Vignola Mark J. now holds 91,940 shares, worth roughly $0.63 million.
Oppenheimer initiated its Terns Pharmaceuticals Inc [TERN] rating to an Outperform in a research note published on October 31, 2024; the price target was $82. A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in late June with a ‘”a Buy”‘ rating. Jefferies began covering TERN with “Buy” recommendation on June 07, 2023. ROTH MKM started covering the stock on May 31, 2023. It rated TERN as “a Buy”.
Price Performance Review of TERN
On Tuesday, Terns Pharmaceuticals Inc [NASDAQ:TERN] saw its stock fall -2.58% to $6.80. Over the last five days, the stock has lost -1.73%. Terns Pharmaceuticals Inc shares have risen nearly 4.78% since the year began. Nevertheless, the stocks have risen 7.09% over the past one year. While a 52-week high of $11.40 was reached on 09/10/24, a 52-week low of $4.32 was recorded on 04/19/24. SMA at 50 days reached $6.81, while 200 days put it at $7.07.
Levels Of Support And Resistance For TERN Stock
The 24-hour chart illustrates a support level at 6.69, which if violated will result in even more drops to 6.57. On the upside, there is a resistance level at 7.01. A further resistance level may holdings at 7.22. The Relative Strength Index (RSI) on the 14-day chart is 52.66, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.23, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 40.24%. Stochastics %K at 63.38% indicates the stock is a holding.
How much short interest is there in Terns Pharmaceuticals Inc?
A steep rise in short interest was recorded in Terns Pharmaceuticals Inc stocks on 2024-11-29, growing by 0.85 million shares to a total of 5.39 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 4.54 million shares. There was a rise of 15.7%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on May 08, 2023 when BMO Capital Markets began covering the stock and recommended ‘”an Outperform”‘ rating along with a $18 price target.
